Alliance Pharma plc (APH) to Issue GBX 0.44 Dividend
Alliance Pharma plc (LON:APH) declared a dividend on Wednesday, September 13th, Upcoming.Co.Uk reports. Investors of record on Thursday, December 21st will be given a dividend of GBX 0.44 ($0.01) per share on Thursday, January 11th. This represents a dividend yield of 0.84%. The ex-dividend date is Thursday, December 21st. The official announcement can be seen at this link.
Shares of Alliance Pharma (LON APH) traded up GBX 1 ($0.01) on Friday, reaching GBX 62.50 ($0.84). The company had a trading volume of 320,179 shares, compared to its average volume of 364,843. Alliance Pharma has a 12 month low of GBX 41.78 ($0.56) and a 12 month high of GBX 63 ($0.85).
A number of analysts recently issued reports on APH shares. FinnCap restated a “buy” rating and issued a GBX 58 ($0.78) price target on shares of Alliance Pharma in a research report on Thursday, August 24th. Numis Securities restated a “buy” rating and issued a GBX 66 ($0.89) price target (down from GBX 71 ($0.96)) on shares of Alliance Pharma in a research report on Friday, December 1st. Investec started coverage on Alliance Pharma in a research report on Wednesday, September 13th. They issued a “buy” rating and a GBX 59 ($0.79) price target for the company. Finally, N+1 Singer restated a “not rated” rating on shares of Alliance Pharma in a research report on Wednesday, September 13th.
Alliance Pharma plc is a United Kingdom-based specialty pharmaceutical company. The Company is engaged in acquisition, marketing and distribution of pharmaceutical products. The Company operates in various business areas, such as Hydromol, secondary care, community and consumer products, established products and international.
Receive News & Ratings for Alliance Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alliance Pharma and related companies with MarketBeat.com's FREE daily email newsletter.